Navigation Links
A Simple Way to Detect Breast Cancer at 'Stage 0' Discovered

GERMANTOWN, Md., July 22, 2011 /PRNewswire/ -- RNL Natural Co., Ltd, a leading biotech company specialized in adult stem cell therapeutics affiliated with RNL BIO Co., Ltd., introduced on June 22, 2011 a new method of detecting breast cancer as early as at 'stage 0' through breath VOCs (volatile organic compounds, a predictor of breast cancer).

Researchers at RNL conducted a study of 35 women diagnosed with breast cancer and 35 healthy women not suffering from the disease. These women participated in the study using breath analysis for breast cancer detection. Results showed that this method demonstrated and visualized distinct patterns for each group, which can help physicians with screening breast cancer patients at a very early stage just by breath before diagnostic confirmation in later stages and saving more lives.

The newly developed technology was inspired from canines' ability that recognizes distinct scents in an extremely sensitive manner. Researchers explain that the machine is able to recognize patterns of VOCs.

Dr. Ra of RNL who led the research stated, "1 out of every 8 women are diagnosed with breast cancer and there has been a yearly increase of 15% of breast cancer found in women. With the breathalyzer, there is a pathway for breast cancer to be detected at the earliest stages and treatment can be started sooner."  In addition, "this method of screening is simple and painless. It is available to women who are concerned about the disease and can get tested sooner. Costs are also lower for screening and treatment through the breathalyzer."

Furthermore, "As we identified adipose stem cells' cancer suppression effect, we could establish a full lineup from early detection to cancer treatment with combining stem cell therapy with testing by the breathalyzer for breast cancer detection will be more efficient. We are continuing to find ways to prevent further progression of diseases like breast cancer through early detection and treatment," Dr. Ra added.  

This phenomenal breakthrough in technology is patent pending and will be published by the end of this year.

About RNL Group

RNL Bio is a premier biopharmaceutical company focused on development and commercialization of early cancer detection, cancer vaccine and adult stem cell therapeutics. Headquartered in Seoul with state-of-the-art GMP facility, RNL is publicly traded company on the Korea Exchange (Code 003190) and strives to become a global leader across the biomedical industry.

RNL Life Science is a majority owned subsidiary of RNL BIO. It distributes RNL group's technology and products in American market.

SOURCE RNL Natural Co., Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simple Test Accurately Predicts Risk of Serious Jaundice in Newborns
2. American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission
3. Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
4. 2009 H1N1 Flu Test From Quest Diagnostics Now CE Marked For International Distribution Under The Simplexa(TM) Brand Name
5. Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer
6. Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced
7. arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development
8. Sensitechs Groundbreaking TempTale(R)4 USB Dry Ice Temperature Monitor Provides Fast, Simple, Efficient Cold Chain Visibility
9. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
10. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
11. Group Practice Forum Launches Fromer-GPF Patient Journey Providing Physicians with Simple Solutions to Improve Patient Care
Post Your Comments:
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
(Date:12/1/2015)... 2015 Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country of ... registered in Europe in 2015 were tested in ... Russia has always been a country of choice for ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):